Data compiled by Redley Lamar · ChainSifter Intelligence
2Suppliers
7Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Scinai Immunotherapeutics Ltd. (SCNI) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
18Total relationships
2Distinct source URLs
10High confidence
0.813Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Scinai Immunotherapeutics Ltd. Suppliers
Ticker
Name
Confidence
Evidence
RECIPHARM-ISRAEL-LTD
RECIPHARM-ISRAEL-LTD
92%
On February 17, 2026, we acquired 100% of the shares of Recipharm Israel Ltd., which operates a manufacturing site in Yavne, Israel, and entered into a long-term strategic commercial collaboration wi…
Reciprocal relationship from MLTX graph: LK through Phase 3 development and regulatory approval will require us to expand commercialization preparation activities and incur related expenses before we…
Scinai Immunotherapeutics Ltd. Customers
Ticker
Name
Confidence
Evidence
SNYNF
Sanofi
72%
e Israeli Ministry of Environmental Protection in order to verify compliance with relevant instructions and regulations. In addition, all of our laboratory personnel participate in instruction on the…
SNYNF
Sanofi
72%
Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCNI graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCNI graph: e Israeli Ministry of Environment…
RECIPHARM-AB-RECIPHARM-ISRAEL-LTD
RECIPHARM-AB-RECIPHARM-ISRAEL-LTD
62%
NOTE 15:- FINANCIAL INCOME (EXPENSES), NET Year ended December 31, 2025 2024 2023 Income: Exchange differences, net $ - $ - - Remeasurement of warrants liabilities 3 91 4,024 Bank deposits 20 100 79 …
RECIPHARM-ISRAEL-LTD
RECIPHARM-ISRAEL-LTD
62%
significant unmet medical need. 40 CDMO Services On September 6, 2023, we announced the launch of a new business unit, Scinai Bioservices (now renamed Scinai Biopharma Services), focused on providing…
RK-STONE-MIAMI-LLC
RK-STONE-MIAMI-LLC
62%
amount has a maturity date of December 31, 2031, is not prepayable in advance, and no interest accrues or is due and payable on such amount. Research and development grants received from the European…
STRATEGIC-COMMERCIAL-CO
STRATEGIC-COMMERCIAL-CO
62%
nd small-molecule programs. This expanded platform is intended to support a wider range of customer needs and increase our ability to attract and retain clients. Strategic Commercial Collaboration wi…
YA-II-PN-LTD
YA-II-PN-LTD
62%
amount has a maturity date of December 31, 2031, is not prepayable in advance, and no interest accrues or is due and payable on such amount. Research and development grants received from the European…
Scinai Immunotherapeutics Ltd. Debt Obligations
Instrument
Description
Confidence
Evidence
SCNI-DEBT
Debt stack $382,000
90%
Market cache reports total debt of $382,000.
SCNI-DEBT-12421
Warrants outstanding: 1638062
90%
xbrl warrant detail from xbrl 2025-07-31.
Scinai Immunotherapeutics Ltd. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Scinai Immunotherapeutics Ltd..
Scinai Immunotherapeutics Ltd. Ownership
Holder
Name
Confidence
Evidence
SCNI-OWNER-CITADEL-ADVISORS-LLC
Citadel Advisors Llc
95%
13F/ownership overlay lists Citadel Advisors Llc; shares held 34,562; ownership 0.98%; value $25,472; as of 2025-12-31.
SCNI-OWNER-VIRTU-FINANCIAL-LLC
Virtu Financial LLC
95%
13F/ownership overlay lists Virtu Financial LLC; shares held 15,409; ownership 0.44%; value $11,356; as of 2025-12-31.
SCNI-OWNER-RHUMBLINE-ADVISERS
Rhumbline Advisers
95%
13F/ownership overlay lists Rhumbline Advisers; shares held 1,878; ownership 0.05%; value $1,384; as of 2025-12-31.
SCNI-OWNER-MORGAN-STANLEY
Morgan Stanley
95%
13F/ownership overlay lists Morgan Stanley; shares held 58; value $42; as of 2025-12-31.
SCNI-OWNER-XTX-TOPCO-LTD
Xtx Topco Ltd
95%
13F/ownership overlay lists Xtx Topco Ltd; shares held 27,294; ownership 0.77%; value $20,115; as of 2025-12-31.
SCNI-OWNER-UBS-GROUP-AG
UBS Group AG
95%
13F/ownership overlay lists UBS Group AG; shares held 1,748; ownership 0.05%; value $1,288; as of 2025-12-31.
